Faculty

Dr Mallar Chakravarty, Radio-Canada

admin — Mon, 08 Dec 2025 19:03:52 +0000

Les conséquences du cannabis durant la grossesse. Écoutez ici

Dr. Gustavo Turecki Named to Clarivate’s Highly Cited Researchers List

admin — Mon, 08 Dec 2025 19:12:57 +0000

Clarivate has released its 2025 Highly Cited Researchers™ (HCRs) list, recognizing scientists whose publications rank among the top 1% most cited worldwide in their fields. This year, 24 91˿��Ƶ researchers, including 11 members of the Faculty of Medicine and Health Sciences (FMHS), earned this distinction. Congratulations to Dr. Turecki for being among this select group of globally influential researchers!

Dr. Bruno Giros named to IUPHAR Neuropsychopharmacology Committee

admin — Mon, 08 Dec 2025 19:01:35 +0000

Dr. Bruno Giros has been appointed to the Neuropsychopharmacology Committee of the International Union of Basic and Clinical Pharmacology (IUPHAR) as the representative of the Canadian Society for Pharmacology and Therapeutics (CSPT). This appointment recognizes his outstanding expertise in neuropharmacology and his commitment to advancing research on neuropsychiatric and neurodegenerative disorders.

Dr Gustavo Turecki, TVA Nouvelles

admin — Mon, 08 Dec 2025 19:02:33 +0000

Avancées en psychiatrie: «Ce n’est pas difficile de traiter la dépression». Écoutez ici

Dre Rachel Rabin, La Presse

admin — Mon, 08 Dec 2025 18:54:27 +0000

Cannabis : Des gènes clés de la dépendance découverts. Lire ici

[VIRTUAL] Feindel Brain and Mind Seminar Series: The Humanity of the Neurosciences

admin — Mon, 08 Dec 2025 18:56:18 +0000

The Feindel Brain and Mind Seminar Series will advance the vision of Dr. William Feindel (1918–2014), Former Director of the Neuro (1972–1984), to constantly bridge the clinical and research realms.

Dre Cécile Rousseau, Le journal de Montréal

admin — Mon, 08 Dec 2025 18:48:31 +0000

Grand-mère attaquée à coups de hache : « Il faut garder le lien avec nos ados », prévient une pédopsychiatre. Écoutez ici

Psychiatry Awards Night 2025

admin — Mon, 08 Dec 2025 18:59:21 +0000

We’re excited to share highlights from the 40th Annual Departmental Awards Night, hosted by the 91˿��Ƶ Psychiatry Residents’ Association on November 17 at Thomson House. The evening was filled with celebration, laughter, and heartfelt recognition of our residents, site coordinators, and faculty. Congratulations to all nominees and award recipients, and a sincere thank you to everyone who helped make this event so memorable. We look forward to celebrating with you again next year!

Dr. Nicolas Tritsch, Nature

admin — Mon, 08 Dec 2025 18:49:32 +0000

How genetically encoded sensors have lit up neuroscience. Read more

Dr. Rob Whitley, The Global and Mail

admin — Mon, 08 Dec 2025 18:50:56 +0000

Opinion: We owe it to Canadian men and boys to prioritize their mental health. Read more

Dre Linda Booij, La Presse

admin — Mon, 08 Dec 2025 18:53:19 +0000

Troubles alimentaires : attention à l’« OSFED ». Lire ici

27th Annual Neuropsychology Day and Brenda Milner Lecture

admin — Mon, 08 Dec 2025 15:31:25 +0000

The 27th Annual Neuropsychology Day and Brenda Milner Lecture honours the career and achievements of Professor Brenda Milner, an eminent cognitive neuroscientist and pioneer of the discipline of neuropsychology.

Otolaryngology Head and Neck Departmental Grand Rounds

admin — Wed, 26 Nov 2025 20:31:49 +0000

Head & Neck Journal Club

Location: MUHC (RVH) SITE - Room Block ES1.1129

Speaker: Dr. Nidal El-Khatib PGY-6

Dr. Rob Whitley: Global News

admin — Sun, 29 Jun 2025 12:45:49 +0000

June is Men’s Health Month. Listen here

Call for Letters of Intent: Translational Impact Research Program | Cycle 2

admin — Wed, 27 Aug 2025 14:56:59 +0000

D2R | DNA to RNA is launching the next round of funding for the Translational Impact Research (TIR) program. This program supports a select few large-scale translational research projects in RNA-based therapeutics which are expected to have a measurable impact on the health of Canadians. Projects must address the D2R Initiative’s strategic priorities and priority disease areas: oncology, rare diseases, infectious diseases, cardiovascular and cardiometabolic diseases.

Applicant Eligibility:

This competition is open to: